Discover

AMRN
Amarin Corporation plc
14.13
2 x 14.15
1 x 14.31
bid
ask
+
0.02
0.11%
12:21 PM
timesize
Ytd1.18%
1y-5.46%
14.13
day range
14.25
12.96
52 week range
20.90
Open14.25Prev Close14.11Low14.13High14.25Mkt Cap292.14M
Vol6.40KAvg Vol73.09KEPS-0.10P/E-141.25Forward P/E-2.17
Beta0.81Short Ratio12.75Inst. Own17.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-2950-d Avg14.79200-d Avg15.021yr Est1.00

AMRN News

Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript
seekingalpha.com
Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript

Amarin Corporation plc (AMRN) Q2 2026 Earnings Call Transcript

Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short
zacks.com
Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short

AMRN surpasses Q2 earnings estimates despite lower revenues, as cost cuts, rising demand and global

Amarin Q2 Earnings Call Highlights
marketbeat.com
Amarin Q2 Earnings Call Highlights

Amarin NASDAQ: AMRN said its second-quarter results reflected progress in its dual commercial strate

benzinga.com
Amarin Corp Q2 Sales $42.211M Miss $44.550M Estimate

Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $42.211 million which missed the analyst conse

Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
globenewswire.com
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered

Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For

Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
globenewswire.com
Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026

DUBLIN, Ireland and BRIDGEWATER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NAS

Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now
zacks.com
Bears are Losing Control Over Amarin (AMRN), Here's Why It's a 'Buy' Now

Amarin (AMRN) witnesses a hammer chart pattern, indicating support found by the stock after losing s

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 98.9% to $83.59 during Tuesday&#

benzinga.com
Amarin Highlights Recent FDA Approval Of Injectable Apolipoprotein C-III Therapies For Treatment Of

Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular

Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
globenewswire.com
Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving

Clinically Validated, Increasingly Prescribed, Widely Reimbursed, and Affordable, VASCEPA Expected t

Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?
zacks.com
Is Amarin (AMRN) Outperforming Other Medical Stocks This Year?

Here is how Amarin (AMRN) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector

benzinga.com
U.S. Supreme Court Rules In Favor Of Hikma Pharmaceuticals V Amarin Pharmaceuticals Over Patent Infr

https://www.supremecourt.gov/opinions/25pdf/24-889_5i36.pdf

benzinga.com
Amarin Announces New Data From A Post Hoc Analysis Of The REDUCE-IT Trial; Apolipoprotein B More Eff

Amarin Corporation plc (NASDAQ:AMRN) (Amarin), a company committed to advancing the science of cardi

New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
globenewswire.com
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Sugges

DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN)

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%
zacks.com
IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent sha

All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy
zacks.com
All You Need to Know About Amarin (AMRN) Rating Upgrade to Strong Buy

Amarin (AMRN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about t

Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y
zacks.com
Amarin's Q1 Loss Narrower Than Expected, Sales Increase Y/Y

AMRN beats earnings and sales estimates as Vascepa sales rise and cost cuts take hold, while the par

Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript
seekingalpha.com
Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript

Amarin Corporation plc (AMRN) Q1 2026 Earnings Call Transcript

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

benzinga.com
Amarin Corp Q1 Sales $45.132M Beat $43.771M Estimate

Amarin Corp (NASDAQ:AMRN) reported quarterly sales of $45.132 million which beat the analyst consens

Amarin Reports 2026 First Quarter Financial Results
globenewswire.com
Amarin Reports 2026 First Quarter Financial Results

Total Revenue Increased Led by Higher International Sales Generated Positive Cash Flow and Reiterate

Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?
zacks.com
Has Amarin (AMRN) Outpaced Other Medical Stocks This Year?

Here is how Amarin (AMRN) and BioAge Labs, Inc. (BIOA) have performed compared to their sector so fa

Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026
globenewswire.com
Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026

DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMR

benzinga.com
Amarin Highlights 2026 ACC/AHA Dyslipidemia Guideline Emphasizing CV Risk Management In Hypertriglyc

Amarin Corporation plc (NASDAQ:AMRN) ("Amarin"), a company committed to advancing the scienc

Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks
fool.com
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks

Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effo

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know
zacks.com
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know

Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships f

Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now
fool.com
Forget Amarin: This Oft-Overlooked Pharma Powerhouse Is a Better Buy Now

Amarin's results depend on a single medicine that is already facing generic competition. By contrast

benzinga.com
Amarin Published Data In The European Journal Of Preventive Cardiology Showing That VASCEPA Was Asso

Peer-reviewed paper indicates icosapent ethyl (IPE) was associated with fewer total hospitalizations

Amarin Q4 Earnings Call Highlights
defenseworld.net
Amarin Q4 Earnings Call Highlights

Amarin (NASDAQ: AMRN) executives told investors that 2025 marked a "substantial achievement" year as

Amarin Corp Q4 2025 Earnings Call Transcript
benzinga.com
Amarin Corp Q4 2025 Earnings Call Transcript

Amarin Corp Earnings Report: Q4 Overview
benzinga.com
Amarin Corp Earnings Report: Q4 Overview

benzinga.com
Amarin Corp Q4 Adj. EPS $0.01 Beats $(0.56) Estimate, Sales $49.219M Miss $50.619M Estimate

Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.01 per share which beat the analyst cons

Earnings Scheduled For February 25, 2026
benzinga.com
Earnings Scheduled For February 25, 2026

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
Earnings Scheduled For July 30, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
benzinga.com
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Movi

benzinga.com
Earnings Scheduled For March 12, 2025

benzinga.com
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day S

benzinga.com
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mi

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

benzinga.com
Earnings Scheduled For February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

benzinga.com
Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company a

benzinga.com
Earnings Scheduled For November 1, 2023

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 369 companies hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 647 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  On Tuesday, 386 stocks made new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

benzinga.com
Earnings Scheduled For October 27, 2022

Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 1076 companies hit new 52-week lows.